Camurus Ab
Clinical trials sponsored by Camurus Ab, explained in plain language.
-
New shot aims to control rare cancer better than current options
Disease control OngoingThis study is comparing a new, long-acting injection called CAM2029 against standard treatments for people with advanced neuroendocrine tumors of the gut or pancreas. The main goal is to see if the new treatment can keep the cancer from growing for a longer period of time while b…
Phase: PHASE3 • Sponsor: Camurus AB • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New shot aims to shrink painful, swollen livers
Disease control OngoingThis study is testing whether a new injectable medication called CAM2029 can safely reduce liver size and ease symptoms in people with polycystic liver disease. About 71 adults with symptoms like abdominal pain, bloating, and shortness of breath will receive either the real treat…
Phase: PHASE2, PHASE3 • Sponsor: Camurus AB • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC